Immunogenicity and Safety of 2 Doses of Live Attenuated Varicella Vaccine
Clinical trial NCT02173899 · COMPLETED
Trial details
- NCT number
- NCT02173899
- Sponsor
- Changchun Keygen Biological Products Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2014-06-01
- Primary completion
- 2014-08-01
- Enrollment
- 716
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.